-
16.04.2013
Gene therapy with CDNF provides functional benefits in a rat model of Parkinson's disease
Read more
-
04.02.2013
Characterization of mammalian posttranslational modifications of GDNF
Read more
-
03.11.2011
License agreement on sales of recombinant CDNF protein for research use
Read more
-
29.09.2011
CDNF is both neuroprotective and neurorestorative in MPTP mouse model of Parkinson's disease
Read more
-
20.09.2011
Professor Barry Hoffer comments on preclinical CDNF data from rodent models of Parkinson's disease
Read more
-
31.01.2011
Data for chronic infusion of CDNF in rat model of Parkinson's disease
Read more
-
10.01.2011
Syndecan-3 identified as a novel receptor for GDNF
Read more
-
03.11.2010
MANF has a unique mechanism to rescue apoptotic neurons
Read more
-
10.11.2009
Novel CDNF/MANF family of neurotrophic factors (new review article)
Read more
-
25.09.2009
Regulation of Brain-Derived Neurotrophic Factor (BDNF) and Cerebral Dopamine Neurotrophic Factor (CDNF) by anti-Parkinsonian drug therapy in vivo
Read more
-
17.09.2009
Constitutive Ret signaling is protective for dopaminergic cell bodies but not for axonal terminals
Read more
-
03.08.2009
Mesencephalic astrocyte-derived neurotrophic factor is neurorestorative in rat model of Parkinson's disease
Read more
-
15.07.2009
Heparin-binding determinants of GDNF reduce its tissue distribution but are beneficial for the protection of nigral dopaminergic neurons
Read more
-
02.01.2009
The structure of the conserved neurotrophic factors MANF and CDNF explains why they are bifunctional
Read more
-
01.01.2009
Evidence that DmMANF is an invertebrate neurotrophic factor supporting dopaminergic neurons
Read more
-
01.01.2009
MANF is widely expressed in mammalian tissues and differently regulated after ischemic and epileptic insults in rodent brain
Read more
|
